期刊文献+

FUROXAN类化合物作为NO供体在心血管作用方面的研究 被引量:4

Study on Furoxan Derivatives as a class of NO donor in Cardiovascular Effect
下载PDF
导出
摘要 Furoxan即1,2,5-口恶二唑-2-氧化物,具有多种生物活性,近年来对其作为NO供体的研究较多。本文总结了Furoxan类化合物在心血管系统作用方面的研究情况,并结合“MedicinalChemicalHybridization”方法的应用,列举了已合成的哌唑嗪的Furoxan类似物和硝苯地平的Furoxan类似物。简介了Furoxan释放NO的机制及有关化合物的构效关系及生物活性。 The furoxan (Furazan oxide; 1,2,5 oxadiazole 2 oxide) derivatives possessing wide ranging biological activity have caused much discussion and controversy since its first preparation. The results obtained in the study of the furoxan derivatives as NO donor were reported in the present paper. It was noted that some fused benzofuroxan derivatives, 3,4 disubstituted furoxancarboxamides had the distinct vasodilation effects and 4 methyl 3 (arylsulfonyl)furoxans possessed the most potent inhibiting activity of platelet aggregation among all derivatives concerned. The technique of “medicinal chemical hybridization” or “symbiotic approach” in the design of new drugs for antihypertensive treatment was introduced, and the resulting hybrids, some furoxan analogues of prazosin and nifedipine were described. The mechanism releasing NO from furoxans was also discussed.
出处 《药学进展》 CAS 1997年第1期14-19,共6页 Progress in Pharmaceutical Sciences
关键词 NO FUROXAN NO供体 血管扩张作用 Furoxans Benzofuroxans NO donor Vasodilating activity
  • 相关文献

同被引文献60

  • 1贾蒙.抗血小板药物的研究进展[J].医学综述,2005,11(6):534-536. 被引量:15
  • 2李战雄,唐松青.氧化呋咱衍生物的合成研究进展[J].含能材料,2006,14(1):77-79. 被引量:13
  • 3Dam M, Tonin P,de Boni A, et al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke, 1996,27 ( 7 ) : 1211-1214
  • 4Braquet P,Touqui L, Shen TY, et al. Perspectives in platelct activating factor research. Pharmacol Rev, 1987,39 (2) :97-145
  • 5Lipton A, Scialla S, Harvey H, et al. Adjuvant antiplatelet therapy with aspirin in colo-rectal cancer. J Med. 1982,13(5-6) : 419-429
  • 6Nash GF,Tumer LF, Scully MF, et al. Platelet and cancer. The Lancet Oncology, 2002,3:425-430
  • 7Bakewell SJ, Nestor P, Prasad S, et al. Platelet and osteoclast beta3 integrins are critical for bone metastasis. Proe Natl Aead Sei USA. 2003, 100(24) : 14205-14210
  • 8Bando H, Yamashita T, Tsubura E. Effects of antiplatelet agents on pulmonary metastases. Gann. 1984 ;75 (3) :284-291
  • 9Ochmanski W. Influence of antiplatelct drugs (AD) on the efectiveness of combined therapy of small cell lung cancer. Part Ⅱ. Influence of treatment on time of remission and patients survival. Przegl Lek. 2008,65 (7-8) :321-318
  • 10Al-Mondhiry H. Tumor interaction with hemostasis: the rationale for the use of platelet inhibitors and anticoagulants in the treatment of cancer. Am J Hematol. 1984,16(2) :193-202

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部